Ador Multi Products Ltd
Incorporated in 1986, Ador Multiproducts Ltd manufactures and distributes cosmetic and personal care products[1]
- Market Cap ₹ 106 Cr.
- Current Price ₹ 111
- High / Low ₹ 119 / 23.4
- Stock P/E
- Book Value ₹ 32.5
- Dividend Yield 0.00 %
- ROCE -11.4 %
- ROE -3.09 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.42 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -26.1% over past five years.
- Company has a low return on equity of -32.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.80 | 6.69 | 6.57 | 7.28 | 9.87 | 19.34 | 13.44 | 12.17 | 6.73 | 2.18 | 1.96 | |
| 6.76 | 8.02 | 7.35 | 8.56 | 12.96 | 20.42 | 19.81 | 20.69 | 10.17 | 2.64 | 2.75 | |
| Operating Profit | -0.96 | -1.33 | -0.78 | -1.28 | -3.09 | -1.08 | -6.37 | -8.52 | -3.44 | -0.46 | -0.79 |
| OPM % | -16.55% | -19.88% | -11.87% | -17.58% | -31.31% | -5.58% | -47.40% | -70.01% | -51.11% | -21.10% | -40.31% |
| 0.14 | 2.27 | 0.16 | 0.18 | 0.54 | 4.27 | 0.30 | 0.31 | 0.96 | -2.03 | -2.64 | |
| Interest | 0.32 | 0.34 | 0.20 | 0.07 | 0.38 | 0.29 | 0.31 | 0.15 | 0.30 | 0.10 | 0.06 |
| Depreciation | 0.18 | 0.09 | 0.12 | 0.20 | 0.26 | 0.36 | 0.43 | 0.69 | 0.53 | 0.60 | 0.35 |
| Profit before tax | -1.32 | 0.51 | -0.94 | -1.37 | -3.19 | 2.54 | -6.81 | -9.05 | -3.31 | -3.19 | -3.84 |
| Tax % | -34.09% | 45.10% | 3.19% | -0.73% | -10.66% | 40.94% | 1.91% | 0.66% | 21.45% | -0.63% | |
| -0.88 | 0.28 | -0.97 | -1.36 | -2.85 | 1.50 | -6.93 | -9.11 | -4.02 | -3.17 | -3.83 | |
| EPS in Rs | -3.07 | 0.98 | -3.39 | -3.62 | -7.19 | 3.21 | -14.83 | -19.49 | -9.78 | -4.22 | -7.43 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -26% |
| 3 Years: | -45% |
| TTM: | -32% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 25% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 12% |
| 3 Years: | 15% |
| 1 Year: | 238% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -32% |
| 3 Years: | -33% |
| Last Year: | -3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.86 | 2.86 | 2.86 | 3.76 | 3.96 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 9.56 |
| Reserves | -0.49 | 2.54 | 0.94 | 1.74 | 3.87 | 8.79 | 16.07 | 10.55 | 6.36 | 4.39 | 21.48 |
| 2.32 | 2.57 | 0.50 | 0.59 | 4.23 | 2.58 | 0.61 | 0.06 | 0.00 | 0.00 | 0.00 | |
| 1.48 | 2.01 | 1.93 | 2.65 | 4.84 | 2.89 | 2.46 | 3.63 | -2.91 | -5.35 | -5.96 | |
| Total Liabilities | 6.17 | 9.98 | 6.23 | 8.74 | 16.90 | 18.93 | 23.81 | 18.91 | 8.12 | 3.71 | 25.08 |
| 1.15 | 5.34 | 1.29 | 2.20 | 6.77 | 7.69 | 8.74 | 8.17 | 3.33 | 1.79 | 1.70 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.26 | 1.37 | 1.40 | 3.00 | 0.13 | 0.86 | 0.61 | 0.62 | 0.61 | 0.54 | 20.98 |
| 4.76 | 3.27 | 3.54 | 3.54 | 10.00 | 10.38 | 14.46 | 10.12 | 4.18 | 1.38 | 2.40 | |
| Total Assets | 6.17 | 9.98 | 6.23 | 8.74 | 16.90 | 18.93 | 23.81 | 18.91 | 8.12 | 3.71 | 25.08 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 9.43 | -3.52 | -0.56 | -3.68 | -7.06 | -8.62 | -6.76 | 0.87 | 0.17 | |
| 0.00 | -3.17 | 3.63 | -2.89 | 3.18 | 4.19 | -0.90 | 0.19 | 0.23 | 0.18 | |
| 0.00 | 0.03 | 0.05 | 3.45 | 1.09 | 2.69 | 12.91 | 0.36 | -0.03 | -0.10 | |
| Net Cash Flow | 0.00 | 6.29 | 0.16 | -0.01 | 0.59 | -0.18 | 3.40 | -6.20 | 1.08 | 0.26 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 67.97 | 64.38 | 87.22 | 65.68 | 91.71 | 35.48 | 43.72 | 39.59 | 10.30 | 28.46 |
| Inventory Days | 107.30 | 102.89 | 68.10 | 82.64 | 197.54 | 136.34 | 204.03 | 201.72 | 93.23 | 242.53 |
| Days Payable | 89.71 | 82.47 | 66.57 | 95.04 | 184.51 | 86.86 | 179.32 | 239.78 | 71.63 | 84.05 |
| Cash Conversion Cycle | 85.56 | 84.79 | 88.75 | 53.28 | 104.75 | 84.95 | 68.43 | 1.53 | 31.90 | 186.95 |
| Working Capital Days | -78.03 | -79.66 | 59.44 | 17.05 | -98.74 | 18.87 | 89.35 | -9.60 | 78.64 | -11.72 |
| ROCE % | -19.75% | -12.55% | -25.02% | -34.54% | -9.54% | -41.27% | -66.42% | -33.55% | -11.44% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
2d - Board approved Q2/H1 unaudited results; sell Aura Flow; buy remaining 47.25% in 1908 E-Ventures (14 Nov 2025).
-
Announcement under Regulation 30 (LODR)-Acquisition
2d - Approved Q2/H1 Sep 30, 2025 unaudited results; sell Aura Flow; acquire remaining 47.25% of 1908 E-Ventures.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th Nov, 2025
2d - Board approved Q2/H1 Sep 30, 2025 results; dispose Aura Flow; acquire remaining 47.25% of 1908 E‑Ventures.
-
Results - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2025
2d - Unaudited Q2/H1 Sep 30, 2025 results: consolidated loss Rs.68.13 lakh, standalone loss Rs.66.91 lakh; limited review.
-
Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September, 2025
10 Nov - Board meeting on 14 Nov 2025 to approve Q2/H1 unaudited results; trading window closed until 16 Nov.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
Company is a contract manufacturer of personal care products in India, offering one-stop shop from product conception to finished goods and undertaking private labelling